While a similar trend of TRAIL-R4 upregulation was observed in patients with del(8)(p21), this did not reach statistical significance possibly due to the use of a smaller sample size for flow cytometric phenotyping.
← all excerpts
Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma.
1
—
—